Novartis Vaccines and Diagnostics - Region North America re-org

Okay, 6 months for most. 9-12 months for all others

 

Not sure if I agree. As compared to GSK, it seems that CSL will need most of the Novartis flu functions/people for continued operation and there is a lot less redundancy.

 

From total GSK Vaccines ops after merger

 

Throwback Thursday:

Do you recognize anyone now at Novartis Vaccines in this story?

www.redorbit.com/news/health/408358/a_case_of_broken_trust/

 

Yes, GSK will make redundant most. Sad end for NVS people...thank you incompetent senior mgt for being unable to stand by the 'caring and curing' principle of NVS! The big shots come our smelling like roses, making millions, the little guys get hosed

 

Only made it to 478,000+ views before the switchover to GSK

 

Check NY Times online story today, March 2, 2015.

 

"GSK, which now plans to return £4bn ($6.2bn) to shareholders, said it would provide an in-depth view of its prospects at an investor meeting to be held when it reports first-quarter results on May 6."

Return $6.2B to shareholders. Gee, I wonder how they're going to do that?

 

Massive headcount reductions. That's how. News flash for all Novartis Vaccines staff who transferred to GSK... Any and everything you are working on today that is a product of the former organization is merely busy work. While it may have transferred, none of it will be used. New systems, new SOPs, etc - you can keep punching the clock on it, but it's wasted effort and a lost cause.

Mark my work - by Monday, June 1, you will know. In the meantime, find what's next for you while you have a paycheck with your name on it. Won't be long now.

 

Word.

 

June 1. You think we have THAT long?

 

Couple of months at best!
By the way what about Cambridge?? NOT...
Where is the FLT and the executive team??? They are all getting jobs at nvs

 

yep. In the legal for example, all but one management-level folks are staying with nvs, and the one that's not is basically retiring.

 

First thing they did was fight and claw for FT jobs with NVS or get their visas taken care of... then after that was given out, they worked on transition related work.

 

Of course....! All want to be here, enjoy our freedoms, equality, opportunities...outsource...critique regulatory requirements, the FDA doesn't approve fast enough. The SEC has too many rules, too much regulation, too much litigation....but they want the sales...pathetic

 

Rino appointed Chief Scientist at GSK Vaccines

 

Makes sense -
I'm sure they plan to keep the Siena site for that reason too. Can't say the same for Cambridge...

 

It has already been confirmed Cambridge is not the US site for vaccines R&D

 

How was Day 1 for everyone?

 

Then only two possible locations for GSK US Vaccine. Either PA or RTP